Théodora Maillard

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Transforming Growth Factor

Peripheral Nerve

Top Venues

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Simon Perrin, Sanela Protic, Vincent Bretegnier, Ingrid Laurendeau, Oriane Duchamp de Lageneste, Nicolas Panara, Odile Ruckebusch, Marine Luka, Cecile Masson, Théodora Maillard, Fanny Coulpier, Stéphanie Pannier, Philippe Wicart, Smail Hadj-Rabia, Katarzyna J Radomska, Mohammed Zarhrate, Mickael Ménager, Dominique Vidaud, Piotr Topilko, Béatrice Parfait, Céline Colnot
MEK-SHP2 inhibition prevents tibial pseudarthrosis caused by NF1 loss in Schwann cells and skeletal stem/progenitor cells. Science translational medicine 16 (753) (2024)
Simon Perrin, Sanela Protic, Vincent Bretegnier, Ingrid Laurendeau, Oriane Duchamp de Lageneste, Nicolas Panara, Odile Ruckebusch, Marine Luka, Cecile Masson, Théodora Maillard, Fanny Coulpier, Stéphanie Pannier, Philippe Wicart, Smail Hadj-Rabia, Katarzyna J Radomska, Mohammed Zarhrate, Mickael Ménager, Dominique Vidaud, Piotr Topilko, Béatrice Parfait, Céline Colnot
MEK-SHP2 inhibition prevents tibial pseudarthrosis caused by NF1 loss in Schwann cells and skeletal stem/progenitor cells. Science translational medicine 16 (753) (2024)
Simon Perrin, Sanela Protic, Vincent Bretegnier, Ingrid Laurendeau, Oriane Duchamp de Lageneste, Nicolas Panara, Odile Ruckebusch, Marine Luka, Cecile Masson, Théodora Maillard, Fanny Coulpier, Stéphanie Pannier, Philippe Wicart, Smail Hadj-Rabia, Katarzyna J Radomska, Mohammed Zarhrate, Mickael Ménager, Dominique Vidaud, Piotr Topilko, Béatrice Parfait, Céline Colnot
MEK-SHP2 inhibition prevents tibial pseudarthrosis caused by NF1 loss in Schwann cells and skeletal stem/progenitor cells. Science translational medicine 16 (753) (2024)
Simon Perrin, Sanela Protic, Vincent Bretegnier, Ingrid Laurendeau, Oriane Duchamp de Lageneste, Nicolas Panara, Odile Ruckebusch, Marine Luka, Cecile Masson, Théodora Maillard, Fanny Coulpier, Stéphanie Pannier, Philippe Wicart, Smail Hadj-Rabia, Katarzyna J Radomska, Mohammed Zarhrate, Mickael Ménager, Dominique Vidaud, Piotr Topilko, Béatrice Parfait, Céline Colnot
MEK-SHP2 inhibition prevents tibial pseudarthrosis caused by NF1 loss in Schwann cells and skeletal stem/progenitor cells. Science translational medicine 16 (753) (2024)